Stephen V Liu and Joachim Aerts
Feb 4, 2025, 09:23
Stephen V Liu: Prediction on the future of 1st line immunotherapy for NSCLC
Stephen V Liu, Associate Professor of Medicine at Georgetown University, shared a post on X:
“Dr. Joachim Aerts offers a prediction on the future of 1L immunotherapy for NSCLC at ITCD2025.
Excitement about bispecific antibiotics including ivonescimab.
Will cancer vaccines make an impact here?”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 5, 2025, 18:30
Aug 5, 2025, 18:18
Aug 5, 2025, 18:04
Aug 5, 2025, 17:52
Aug 5, 2025, 16:29
Aug 5, 2025, 16:07
Aug 5, 2025, 16:04